What is Akebia Therapeutics, Inc.'s Market Cap?

Akebia Therapeutics, Inc.'s Market Cap is $264.3M, based on as-reported figures from SEC (XBRL) filings.

What is Akebia Therapeutics, Inc.'s Enterprise Value?

Akebia Therapeutics, Inc.'s Enterprise Value is $158.3M, based on as-reported figures from SEC (XBRL) filings.

What is Akebia Therapeutics, Inc.'s Price / Sales?

Akebia Therapeutics, Inc.'s Price / Sales is 1.2×, based on as-reported figures from SEC (XBRL) filings.

What is Akebia Therapeutics, Inc.'s EV / Revenue?

Akebia Therapeutics, Inc.'s EV / Revenue is 0.7×, based on as-reported figures from SEC (XBRL) filings.

What is Akebia Therapeutics, Inc.'s EV / EBITDA?

Akebia Therapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Akebia Therapeutics, Inc.'s Revenue (TTM)?

Akebia Therapeutics, Inc.'s Revenue (TTM) is $219.1M, based on as-reported figures from SEC (XBRL) filings.

What is Akebia Therapeutics, Inc.'s Net Income (TTM)?

Akebia Therapeutics, Inc.'s Net Income (TTM) is -$29.7M, based on as-reported figures from SEC (XBRL) filings.

What is Akebia Therapeutics, Inc.'s EBITDA?

Akebia Therapeutics, Inc.'s EBITDA is -$13.6M, based on as-reported figures from SEC (XBRL) filings.

What is Akebia Therapeutics, Inc.'s Diluted EPS (TTM)?

Akebia Therapeutics, Inc.'s Diluted EPS (TTM) is -0.11, based on as-reported figures from SEC (XBRL) filings.

What is Akebia Therapeutics, Inc.'s EBITDA Margin?

Akebia Therapeutics, Inc.'s EBITDA Margin is -6.2%, based on as-reported figures from SEC (XBRL) filings.

Akebia Therapeutics, Inc. (AKBA) Financial Statements

Akebia Therapeutics, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001T922S9

XNAS · usd

0.95▼ 0.08 (-7.39%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close1.03

Day's Range0.95 – 1.05

52-Week Range0.81 – 3.20

Volume4.9M

Avg Volume7.4M

Share Statistics

Shares Outstanding

Employees194

ExchangeXNAS

Listed2014-03-20

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Akebia Therapeutics, Inc. (AKBA)

What is Akebia Therapeutics, Inc.'s Market Cap?: Akebia Therapeutics, Inc.'s Market Cap is $264.3M, based on as-reported figures from SEC (XBRL) filings.
What is Akebia Therapeutics, Inc.'s Enterprise Value?: Akebia Therapeutics, Inc.'s Enterprise Value is $158.3M, based on as-reported figures from SEC (XBRL) filings.
What is Akebia Therapeutics, Inc.'s Price / Sales?: Akebia Therapeutics, Inc.'s Price / Sales is 1.2×, based on as-reported figures from SEC (XBRL) filings.
What is Akebia Therapeutics, Inc.'s EV / Revenue?: Akebia Therapeutics, Inc.'s EV / Revenue is 0.7×, based on as-reported figures from SEC (XBRL) filings.
What is Akebia Therapeutics, Inc.'s EV / EBITDA?: Akebia Therapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Akebia Therapeutics, Inc.'s Revenue (TTM)?: Akebia Therapeutics, Inc.'s Revenue (TTM) is $219.1M, based on as-reported figures from SEC (XBRL) filings.
What is Akebia Therapeutics, Inc.'s Net Income (TTM)?: Akebia Therapeutics, Inc.'s Net Income (TTM) is -$29.7M, based on as-reported figures from SEC (XBRL) filings.
What is Akebia Therapeutics, Inc.'s EBITDA?: Akebia Therapeutics, Inc.'s EBITDA is -$13.6M, based on as-reported figures from SEC (XBRL) filings.
What is Akebia Therapeutics, Inc.'s Diluted EPS (TTM)?: Akebia Therapeutics, Inc.'s Diluted EPS (TTM) is -0.11, based on as-reported figures from SEC (XBRL) filings.
What is Akebia Therapeutics, Inc.'s EBITDA Margin?: Akebia Therapeutics, Inc.'s EBITDA Margin is -6.2%, based on as-reported figures from SEC (XBRL) filings.